These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9282626)

  • 21. [Vaccination against hepatitis B in Switzerland: towards a global strategy].
    Kammerlander R; Vaudaux B; Bourquin C; Zimmermann HP; Raeber PA
    Rev Med Suisse Romande; 1998 Apr; 118(4):335-9. PubMed ID: 9623285
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure.
    Agarwal SK; Irshad M; Dash SC
    J Assoc Physicians India; 1999 Feb; 47(2):183-5. PubMed ID: 10999085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transmission of hepatitis B virus by a surgeon].
    Schalm SW; Mazel JA
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):187. PubMed ID: 10668546
    [No Abstract]   [Full Text] [Related]  

  • 25. Serologic response to hepatitis B vaccination in children with isolated anti-Hbc.
    Atabek ME; Erkul I
    J Trop Pediatr; 2006 Feb; 52(1):71-2. PubMed ID: 15917263
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B: the global problem, its prevention and future, and role of IMA.
    Roy S; Chakrabortti SC
    J Indian Med Assoc; 2000 Jul; 98(7):366. PubMed ID: 11143853
    [No Abstract]   [Full Text] [Related]  

  • 27. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low rates of seroconversion after hepatitis B vaccination in orphanges with high prevalence of virus carriers.
    Cernescu C; Ruţă S; Diaconu C; Bleotu C; Grancea C; Truică C; Crăciun D; Nedelcu IN
    Rom J Virol; 1998; 49(1-4):73-81. PubMed ID: 10892428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis B vaccination is still current].
    Kremp O
    Soins Pediatr Pueric; 1999; (187):31-2. PubMed ID: 10615148
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis B vaccination in prisons.
    Awofeso N
    Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

  • 33. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis B virus infection.
    Cherian T; John TJ
    Indian Pediatr; 1997 Aug; 34(8):762-3. PubMed ID: 9508557
    [No Abstract]   [Full Text] [Related]  

  • 35. Newer vaccines--to vaccinate or not to vaccinate is the question: ethical and medicolegal issues.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):791-5. PubMed ID: 10216578
    [No Abstract]   [Full Text] [Related]  

  • 36. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Debate revived on hepatitis B vaccine value.
    Marwick C; Mitka M
    JAMA; 1999 Jul; 282(1):15-7. PubMed ID: 10404894
    [No Abstract]   [Full Text] [Related]  

  • 38. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
    Puliyel JM
    Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatitis B: a controversy for the French].
    Nau JY
    Rev Med Suisse; 2008 Feb; 4(144):440. PubMed ID: 18320777
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis B and vaccination program policy in Finland].
    Leinikki P
    Duodecim; 2002; 118(1):71-2. PubMed ID: 12229000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.